93213 ⎘
Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
AMINO ACID BASED CARBAMATES AND/OR UREAS FOR THE TREATMENT OF SORTILIN DEPENDENT DISEASES
#2BIOTIN-FREE PROXIMITY LABELING
#3ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE
#4CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
#5MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#6PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE
#7PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS
#8MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#9Processes for the preparation of ()-tert-butyl 4,5-diamino-5-oxopentanoate
#10MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#11Heterodimers of Glutamic Acid
#12CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENT
#13Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
#14CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
#15TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
#16MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST
#1718F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
#18Inhibitors of integrin alpha 2 beta 1 and methods of use
#19P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same
#20AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same
#21HETERODIMERS OF GLUTAMIC ACID
#22Compounds for the modulation of cyclophilins function
#23Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast
#24Opioid receptor modulators and products and methods related thereto
#25NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME
#26Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
#27Carbamoyl phenylalaninol analogs and uses thereof
#28Urea group containing anti-sagging rheology control agents
#29HETERODIMERS OF GLUTAMIC ACID
#30HETERODIMERS OF GLUTAMIC ACID
#31Mu opioid receptor modulators
#32MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#33Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate
#34Reactive antibacterial compound and preparation method thereof
#35MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA AND PATHOGENIC YEAST
#36Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast
#37CAPSAZEPINE ANALOGS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
#3818F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
#39Urea compound and preparation method and application thereof
#40Targeting agent antibody conjugates and uses thereof
#41Heterodimers of glutamic acid
#42Reactive antibacterial compound and preparation method thereof
#43Alpha-Ketoamide Inhibitors Of Cysteine Proteases
#44Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
#45TETRACYCLINE COMPOUNDS
#46MU opioid receptor modulators
#47Mu opioid receptor modulators
#48SHIP1 MODULATORS AND METHODS RELATED THERETO
#49Necrosis inhibitors
#50Heterodimers of glutamic acid
#51Reactive antibacterial compound and preparation method thereof
#52INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#5318F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
#54Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#55Ethynylbenzene derivatives
#56Herbicidal compounds
#57Capsazepine analogs for the treatment of cancer and other proliferative diseases
#58UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS
#59PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#60SHIP1 MODULATORS AND METHODS RELATED THERETO
#61Novel Triarylethylene Compounds and Methods Using Same
#62PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#63PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#64PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#65Compositions and methods relating to proliferative diseases
#66Tetracycline compounds
#67Heterodimers of glutamic acid
#68Cancer cell targeting using nanoparticles
#69Heterodimers of glutamic acid
#70OPTICAL ISOMERS OF (+) AND (-)-BENZHYDRYL UREAS AND (+) AND (-)-1-[(3-CHLOROPHENYL)-PHENYL-METHYL] UREA, A PHARMACEUTICAL COMPOSITION BASED THEREON AND A METHOD FOR PRODUCING SAID OPTICAL ISOMERS
#71Active light sensitive or radiation sensitive resin composition, active light sensitive or radiation sensitive film, mask blank provided with active light sensitive or radiation sensitive film, pattern forming method, method for manufacturing electronic device, electronic device and novel compound
#72Methods and compositions for selective and targeted cancer therapy
#73Targeting agent antibody conjugates and uses thereof
#74SHIP1 modulators and methods related thereto
#75Pesticidal compositions and processes related thereto
#76Pesticidal compositions and processes related thereto
#77S1P receptors modulators and their use thereof
#78Pesticidal compositions and processes related thereto
#79Pesticidal compositions and processes related thereto
#80NOVEL PHENICOL ANTIBACTERIALS
#81Synthetic route to pactamycin and pactamycin analogs
#82OMEGA-3 ANALOGUES
#83Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
#84Substituted 4-aminocyclohexane derivatives
#85METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY
#86Compositions and methods relating to proliferative diseases
#87SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY
#88Cancer cell targeting using nanoparticles
#89Pesticidal compositions and processes related thereto
#90Inhibitors of cyclophilins and uses thereof
#91Pesticidal compositions and processes related thereto
#92Pesticidal compositions and processes related thereto
#93Pesticidal compositions and processes related thereto
#94Pesticidal compositions and processes related thereto
#95Enzyme inhibitors
#96Glutamine derivatives as deodorants
#97Pesticidal diaryl—heterocyclyl derivatives
#98S1P receptors modulators and their use thereof
#99Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
#100Ethynylbenzene derivatives
#101Bisurea gelling agents and compositions
#102MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#103Substituted 4-aminocyclohexane derivatives
#104N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#105Enzyme inhibitors
#106Histone deacetylase inhibitors and methods of use thereof
#107Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2
#108Inhibitors of cyclophilins and uses thereof
#109PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#110(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
#111Heterocyclic CETP inhibitors
#112IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA
#113Heterodimers of glutamic acid
#114Oligonucleotide derivative comprising an aromatic compound
#115Compounds, pharmaceutical compositions and uses thereof
#116Heterodimers of glutamic acid
#117Substituted 4-aminocyclohexane derivatives
#118Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#119Pesticidal carboxamides
#120Compositions and methods relating to proliferative diseases
#121Tetracycline compounds
#122Method of treating contrast-induced nephropathy
#123Pentacycline Compounds
#124Method for removing undifferentiated and dedifferentiated stem cell
#125-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#126N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#127METHOD FOR MAKING CARBAMATES, UREAS AND ISOCYANATES
#128Process for the preparation of alogliptin
#129Cancer cell targeting using nanoparticles
#130S1P receptors modulators and their use thereof
#131Cancer cell targeting using nanoparticles
#132UREA DERIVATIVES AS ANTIBACTERIAL AGENTS
#133Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS
#1342-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS
#135Azolin-2-ylamino Compounds for Combating Animal Pests
#136Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
#137Histone deacetylase inhibitors and methods of use thereof
#138N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
#139PREPARATION OF NOVEL 1,3-SUBSTITUTED UREAS AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
#140Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#141N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#142Probes, Systems, and Methods for Drug Discovery
#143Process for production of heterodimers of glutamic acid
#144NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES
#145Substituted aminopropionic derivatives as neprilysin inhibitors
#146SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#147Heterocyclic CETP inhibitors
#148Cell differentiation inducer
#149Rheology control agents
#150Urea oligomers, their preparation process and pharmaceutical compositions containing them
#151PHENYL DERIVATIVES AND METHODS OF USE
#152Renin inhibitors
#153Method for making carbamates, ureas and isocyanates
#154O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists
#155N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#156DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORS
#157N- (2-aminophenyl) benzamide derivative having urea structure
#1587-substituted tetracycline compounds
#159Enzyme inhibitors
#160Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#161SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
#162Antineoplastic compounds and pharmaceutical compositions thereof
#163Benzoyl-Substituted Alanines
#164Aminodicarboxylic acid derivatives having pharmaceutical properties
#165-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#166Histone deacetylase inhibitors and methods of use thereof
#167Glucagon Antagonists/Inverse Agonists
#168NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#169Imaging agents and methods of imaging NAALADase or PSMA
#170Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#171Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
#172Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
#173Compounds to treat alzheimer's disease
#174Cancer cell targeting using nanoparticles
#1751,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
#176SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#177Substituted Ureas and Carbamates
#1781-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors
#179Chemokine receptor modulators
#180Substituted fluoroethyl ureas as alpha 2 adrenergic agents
#181HIV protease inhibitors
#182Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
#183Curcumin analogs with anti-tumor and anti-angiogenic properties
#184Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
#185Substituted amides
#186Certain chemical entities, compositions, and methods
#187Heterodimers of glutamic acid
#188Cell differentiation inducer
#189Fc receptor modulating compounds and compositions
#190Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth) acrylate polymer and its use
#191Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#192Compounds for treatment of inflammation, diabetes and related disorders
#193Organic Compunds
#194Di-aromatic substituted amides as inhibitors for GlyT-1
#195Ceramides and apoptosis-signaling ligand
#196Histone deacetylase inhibitors
#197Naphthalene compounds
#198Therapeutic fluoroethyl ureas
#199Phenylaminoethanol derivatives as β2 receptor agonists
#200Phenethanolamine derivatives for treatment of respiratory diseases
#201Certain chemical entities, compositions, and methods
#202Dibenzyl amine compounds and derivatives
#203Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
#204Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
#205Benzoyl-substituted phenylalanineamides
#206Heterocyclic CETP inhibitors
#207Curable electron donor compositions
#208NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF
#209Cyclic sulfone containing retroviral protease inhibitors
#210NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS
#211Methods of preparing retroviral proteases inhibitor intermediates
#212Fc receptor modulating compounds and compositions
#213(Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
#214Substituted amino acids as erythropoietin mimetics
#215Compounds for the treatment of Alzheimer's disease
#216Method for the synthesis of compounds of formula I and their uses thereof
#217Rheology control agents
#218Method for the sysnthesis of compounds of formula I and their uses thereof
#219Photoinitiators and UV-crosslinkable acrylic polymers for pressure sensitive adhesives
#220Substituted biaryl-carboxylate derivatives
#221Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof
#222Substituted amides
#223Aminodicarboxylic acid derivatives having pharmaceutical properties
#224Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
#225Phenyl derivatives and methods of use
#226Synthesis of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
#227Cyclohexylurea compounds
#228Inhibitors of bacterial type III protein secretion systems
#229Novel anticancer compounds
#230Phenethanolamine derivatives for treatment of respiratory diseases
#231Glucagon antagonists/inverse agonists
#232Compounds to treat Alzheimer's disease
#233Urea and thiourea compounds and compositions for cholesterol management and related uses
#234Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#235Bacterial enzyme inhibitors
#236Urea derivatives
#237Method of preparing retroviral protease inhibitor intermediates
#238Substituted cyclic compounds
#239Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
#240PPAR compounds
#241Substituted cyclic compounds
#242Urea oligomers, the preparation method thereof and pharmaceutical composition containing same
#243Histone deacetylase inhibitors and methods of use thereof
#244Histone deacetylase inhibitors and methods of use thereof
#245Urea linker derivatives for use as PPAR modulators